Showing 9 RESULTS FOR
Innovation
Persevering to Power Brain Health Breakthroughs
Gary O’Neill, site head at our Lundbeck La Jolla Research Center, discusses what it takes to persist in the challenging neuroscience space and how learnings from the COVID-19 pandemic could advance breakthroughs in other areas.
Across the Great Divide: Getting Antibodies into the Brain
A new collaboration studies an essential delivery avenue for innovative brain disease therapies.
Lundbeck Ranked Among World’s Climate Elite
New global ranking puts Lundbeck in the top 2% of more than 8,400 companies evaluated for their actions against climate change.
Stronger Together: Why Collaboration is Critical to Advancing Alzheimer’s Research
By Peter Anastasiou
Lundbeck’s executive vice president and head of North America discusses our collaborative approach to Alzheimer’s research.
Lundbeck to Acquire Abide Therapeutics, Adding a Unique Discovery Platform and a Lead Compound in an Exploratory Phase IIa Program for Tourette’s
Abide’s world-class discovery platform is focused on harnessing the therapeutic potential of one of the largest, most diverse enzyme classes.